Yong-Deok K, Eun-Hyoung J, Yeon-Sun K, Kang-Mi P, Jin-Yong L, Sung-Hwan C, Tae-Yun K, Tae-Sung P, Soung-Min K, Myung-Jin K, Jong-Ho L. Molecular genetic study of novel
biomarkers for early diagnosis of oral squamous cell
carcinoma. Med Oral Patol
Oral Cir Bucal. 2015
Mar 1;20 (2):e167-79.
doi:10.4317/medoral.20229
http://dx.doi.org/doi:10.4317/medoral.20229
|
1. Parkin DM. Global cancer statistics in the year 2000.
Lancet Oncol. 2001;2:533-43. |
|
|
|
|
|
2. Jemal A, Siegel
R, Ward E, Hao Y, Xu J,
Murray T, et al. Cancer
statistics, 2008. CA Cancer J Clin. 2008;58:71-96. |
|
|
|
|
|
3. da Silva SD, Ferlito A, Takes
RP, Brakenhoff RH, Valentin
MD, Woolgar JA, et al. Advances and applications of
oral cancer basic research. Oral Oncol.
2011;47:783-91. |
|
|
|
|
|
4. Sandler
HC. Cytological screening for early mouth cancer. Cancer. 1962;15:1119-24. |
|
|
|
|
|
5. Al-Sarraf M. Chemotherapeutic management of head and neck
cancer. Cancer Metastasis Rev. 1987;6:181-98. |
|
|
|
|
|
6. Rao SK, Pavicevic Z, Du Z, Kim
JG, Fan M, Jiao Y, et al. Pro-inflammatory genes as biomarkers and
therapeutic targets in oral squamous cell
carcinoma. J Biol Chem.
2010; 285:32512-21. |
|
|
|
|
|
7. Ziober AF, Patel KR, Alawi F, Gimotty P, Weber RS, Feldman MM, et al. Identification of
a gene signature for rapid screening of oral squamous
cell carcinoma. Clin Cancer Res. 2006;12:5960-71. |
|
|
|
|
|
8. Reis PP, Waldron
L, Perez-Ordonez B, Pintilie
M, Galloni NN, Xuan Y, et
al. A gene
signature in histologically normal surgical margins
is predictive of oral carcinoma recurrence. BMC
Cancer. 2011;11:437. |
|
|
|
|
|
9. Zhao J,
Rycaj K, Geng S, Li M,
Plummer JB, Yin B, et al. Expression of Human Endogenous Retrovirus Type K
Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast
Cancer. Genes Cancer. 2011;2:914-22. |
|
|
|
|
|
10. Jain
N, Thatte J, Braciale T, Ley K, O'Connell M, Lee JK. Local-pooled-error test for
identifying differentially expressed genes with a small number of replicated
microarrays. Bioinformatics. 2003;19:1945-51. |
|
|
|
|
|
11. Tusher VG, Tibshirani R, Chu G.
Significance analysis of microarrays applied to the ionizing radiation
response. Proc Natl Acad Sci. 2001;98:5116-21. |
|
|
|
|
|
12. Lockstone HE. Exon array data
analysis using Affymetrix power tools and R
statistical software. Brief Bioinform. 2011;12:634-44. |
|
|
|
|
|
13.
Shapiro SS, Wilk MB. An analysis of variance test
for normality (complete samples). Biometrika. 1965;52:591-611. |
|
|
|
|
|
14. Dürkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and
expression of a new member of the nerve growth factor receptor family that is
characteristic for Hodgkin's disease. Cell. 1992;68:421-7. |
|
|
|
|
|
15. Li B, Ouyang B, Pan H, Reissmann PT, Slamon DJ, Arceci R, et al. Prk, a cytokine-inducible human protein serine/threonine kinase whose expression
appears to be down-regulated in lung carcinomas. J Biol Chem. 1996;271:19402-8. |
|
|
|
|
|
16. Bassuny
WM, Ihara K, Kimura J, Ichikawa S, Kuromaru R, Miyako K, et al. Association study between interleukin-12
receptor beta1/beta2 genes and type 1 diabetes or asthma in the Japanese
population. Immunogenetics. 2003;55:189-92. |
|
|
|
|
|
17. Harris
MJ, Arias IM. FIC1, a P-type ATPase linked to cholestatic liver disease, has homologues (ATP8B2 and
ATP8B3) expressed throughout the body. Biochim Biophys
Acta. 2003;1633:127-31. |
|
|
|
|
|
18. Tenca P, Brotherton D, Montagnoli A, Rainoldi S,
Albanese C, Santocanale C.
Cdc7 is an active kinase in human cancer cells
undergoing replication stress. J Biol Chem. 2007;282:208-15. |
|
|
|
|
|
19. Zhong JL, Poghosyan Z,
Pennington CJ, Scott X, Handsley MM, Warn A, et al.
Distinct functions of natural ADAM-15 cytoplasmic
domain variants in human mammary carcinoma. Mol
Cancer Res. 2008;6:383-94. |
|
|
|
|
|
20. Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, et al. Expression and clinical
significance of the Kv3.4 potassium channel subunit in the development and
progression of head and neck squamous cell
carcinomas. J Pathol.
2010;221:402-10. |
|
|
|
|
|
21. Kuwano
Y, Kamio Y, Kawai T, Katsuura S, Inada N, Takaki A, et al. Autism-associated gene expression in
peripheral leucocytes commonly observed between subjects with autism and
healthy women having autistic children. PloS one.
2011;6:e24723. |
|
|
|
|
|
22. Marenholz
I, Rivera VA, Esparza-Gordillo J, Bauerfeind A,
Lee-Kirsch MA, Ciechanowicz A, et al. Association screening in the
Epidermal Differentiation Complex (EDC) identifies an SPRR3 repeat number
variant as a risk factor for eczema. J Invest Dermatol. 2011;131:1644-9. |
|
|
|
|
|
23. Oliver
AW, He X, Borthwick K, Donne AJ, Hampson L, Hampson IN. The
HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates
Cdc42. Br J Cancer. 2011;104:324-31. |
|
|
|
|
|
24. Lenain C, Bauwens S, Amiard S, Brunori M, Giraud-Panis MJ, Gilson E. The Apollo 5' exonuclease
functions together with TRF2 to protect telomeres from DNA repair. Curr Biol. 2006;16:1303-10. |
|
|
|
|
|
25. Pettus JR, Johnson JJ, Shi Z, Davis JW, Koblinski J, Ghosh S, et al. Multiple
kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity. Histol Histopathol. 2009;24:197-207. |
|
|
|
|
|
26. Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z.
Prognostic significance of tumor-related genes hypermethylation
detected in cancer-free surgical margins of oral squamous
cell carcinomas. Oral Oncol.
2011;47:702-8. |
|
|
|
|
|
27. Ahn SM, Kim TH, Lee S, Kim D, Ghang
H, Kim DS, et al. The first Korean genome sequence and analysis: full genome
sequencing for a socio-ethnic group. Genome Res. 2009;19:1622-9. |
|
|
|
|
|
28. Cheong
SC, Chandramouli GV, Saleh
A, Zain RB, Lau SH, Sivakumaren
S, et al. Gene expression in human oral squamous
cell carcinoma is influenced by risk factor exposure. Oral Oncol. 2009;45:712-9. |
|
|
|
|
|
29. Méndez E, Cheng C, Farwell DG, Ricks S, Agoff SN, Futran ND, et al.
Transcriptional expression profiles of oral squamous
cell carcinomas. Cancer. 2002;95:1482-94. |
|
|
|
|
|
30. Chen
C, Méndez E, Houck J, Fan W, Lohavanichbutr
P, Doody D, et al. Gene expression profiling
identifies genes predictive of oral squamous cell
carcinoma. Cancer Epidemiol Biomarkers
Prev. 2008;17:2152-62. |
|
|
|
|
|
31. Yang
Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI.
Integrative genomic data mining for discovery of potential blood-borne
biomarkers for early diagnosis of cancer. PloS one.
2008;3:e3661. |
|
|
|
|
|
32. Lucas
N, Najy AJ, Day ML. The therapeutic potential of
ADAM15. Current pharmaceutical design.
2009;15:2311-8. |
|
|
|
|
|
33. Duffy
MJ, McKiernan E, O'Donovan
N, McGowan PM. Role of ADAMs in cancer formation and
progression. Clin Cancer Res. 2009;15:1140-4. |
|
|
|
|
|
34. Toquet C, Colson A, Jarry A, Bezieau S, Volteau C, Boisseau P, et al. ADAM15 to
alpha5beta1 integrin switch in colon carcinoma
cells: a late event in cancer progression associated with tumor
dedifferentiation and poor prognosis. Int J Cancer.
2012;130:278-87. |
|
|
|
|
|
35. Ungerer C, Doberstein K, Bürger C, Hardt K, Boehncke WH, Böhm B, et al. ADAM15
expression is downregulated in melanoma metastasis
compared to primary melanoma. Biochem Biophys Res Commun. 2010;401:363-9. |
|
|
|
|
|
36. Montagnoli A, Moll J, Colotta
F. Targeting cell division cycle 7 kinase:
a new approach for cancer therapy. Clin Cancer
Res. 2010;16:4503-8. |
|
|
|
|
|
37. Kulkarni AA, Kingsbury SR, Tudzarova
S, Hong HK, Loddo M, Rashid M, et al. Cdc7 kinase is a predictor of survival and a novel therapeutic
target in epithelial ovarian carcinoma. Clin Cancer
Res. 2009;15:2417-25. |
|
|
|
|
|
38.
Rodriguez-Acebes S, Proctor I, Loddo
M, Wollenschlaeger A, Rashid M, Falzon
M, et al. Targeting DNA replication before it starts: Cdc7 as a therapeutic
target in p53-mutant breast cancers. Am J Patho. 2010;177:2034-45. |
|
|
|
|
|
39. Slebos RJ, Yi Y, Ely K, Carter J, Evjen
A, Zhang X, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer
Res. 2006;12:701-9. |
|
|
|
|
|
40.
Pistoia V, Cocco C, Airoldi
I. Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene
in human B-cell malignancies. J Clin Oncol. 2009;27:4809-16. |
|
|
|
|
|
41. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, et al.
Clinical impact of different classes of infiltrating T cytotoxic
and helper cells (Th1, th2, treg, th17) in patients
with colorectal cancer. Cancer Res. 2011;71:1263-71. |
|
|
|
|
|
42. Airoldi
I, Di Carlo E, Cocco C, Sorrentino
C, Fais F, Cilli M, et
al. Lack of
Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. Blood. 2005;106:3846-53. |
|
|
|
|
|
43. Gasche JA, Hoffmann J, Boland CR, Goel
A. Interleukin-6 promotes tumorigenesis by altering
DNA methylation in oral cancer cells. Int J Cancer. 2011;129:1053-63. |
|
|
|
|
|
44. Kang
MR, Kang JS, Yang JW, Kim BG, Kim JA, Jo YN, et al. Gene expression profiling
of KBH-A42, a novel histone deacetylase
inhibitor, in human leukemia and bladder cancer cell lines. Oncol Lett. 2012;3:113-8. |
|
|
|
|
|
45. Agnelli
L, Mereu E, Pellegrino E,
Limongi T, Kwee I, Bergaggio E, et al. (European T-Cell Lymphoma Study Group)
Identification of a three-gene model as a powerful diagnostic tool for the
recognition of ALK negative ALCL. Blood. 2012;120:1274-81. |
|
|
|
|
|
46. Longoni M, Orzan F, Stroppi M, Boari N, Mortini P, Riva P. Evaluation of 1p36 markers and
clinical outcome in a skull base chordoma study. Neuro Oncol. 2008;10:52-60. |
|
|
|
|
|
47. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-5. |
|
|
|
|
|
48. Yin J,
Tian L. Optimal linear combinations of multiple
diagnostic biomarkers based on Youden index. Stat Med. 2014;33:1426-40. |
|
|
|
|